The antiserum was produced against synthesized peptide derived from human IRF-3 around the phosphorylation site of Ser386.
WBELISA
Human
Western blot analysis of extracts from HepG2 cells treated with EGF 200ng/ml 30', using IRF-3 (Phospho-Ser386) Antibody. The lane on the right is treated with the synthesized peptide
滬公網(wǎng)安備 31011702004356號(hào)